Related Experiment Video
Updated: Feb 22, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Piracetam inhibits ethanol (EtOH)-induced memory deficit by mediating multiple pathways
Yifan Yang1, Jian Feng2, Fangyuan Xu3
1Department of Neurology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.
Insights
Piracetam (Pir) protects against ethanol-induced memory deficits and neurotoxicity in juvenile rats. This nootropic drug safeguards hippocampus neurons by reducing apoptosis and regulating autophagy via the mTOR/Akt pathway.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Prenatal and excessive ethanol (EtOH) exposure causes significant cognitive deficits and learning/memory impairments in children.
- Ethanol neurotoxicity is a growing concern, necessitating effective protective strategies.
- Piracetam (Pir), a nootropic agent, shows potential for managing cognitive impairments, but its mechanism against EtOH-induced damage is unclear.
Purpose of the Study:
- To investigate the protective mechanisms of Piracetam against ethanol-induced neurotoxicity and cognitive deficits.
- To elucidate the pathways involved in Piracetam's therapeutic effects on ethanol-induced memory impairments.
Main Methods:
- Assessment of cognitive function and synaptic plasticity (long-term potentiation) in juvenile rats exposed to ethanol.
- Evaluation of Piracetam's effects on hippocampus neuron apoptosis, Caspase-3 activation, and autophagy markers (LC3-II, Beclin-1).
- Analysis of the mTOR/Akt signaling pathway's involvement in Piracetam's neuroprotective action.
Main Results:
- Ethanol exposure induced cognitive deficits and altered synaptic plasticity in juvenile rats.
- Piracetam administration significantly improved long-term potentiation and protected hippocampus neurons from ethanol toxicity.
- Piracetam demonstrated anti-apoptotic effects by inhibiting Caspase-3 activation and modulated autophagy by affecting LC3-II, Beclin-1, and mTOR/Akt pathways.
Conclusions:
- Piracetam mitigates ethanol-induced cognitive deficits and neurotoxicity in juvenile rats.
- The protective effects are mediated through the inhibition of neuronal apoptosis and the regulation of autophagic processes via the mTOR/Akt pathway.
- This study provides preclinical evidence supporting Piracetam's application in managing ethanol toxicity.
Abstract:
Excessive ethanol (EtOH) intake, especially to prenatal exposure, can significantly affect cognitive function and cause permanent learning and memory injures in children. As a result, how to protect children from EtOH neurotoxicity has gained increasing attention in recent years. Piracetam (Pir) is a nootropic drug derived from c-aminobutyric acid and can manage cognition impairments in multiple neurological disorders. Studies have shown that Pir can exert therapeutic effects on EtOH-induced memory impairments, but the underlying mechanism is still unknown. In this study, we found that Pir inhibited ethanol-induced memory deficit by mediating multiple pathways. Treatment with EtOH could cause cognitive deficit in juvenile rats, and triggered the alteration of synaptic plasticity. Administration with Pir significantly increased long-term potentiation and protected hippocampus neurons from EtOH neurotoxicity. Pir intervention ameliorated EtOH-induced cell apoptosis and inhibited the activation of Caspase-3 in vitro, suggesting that Pir protected neurons by anti-apoptotic effects. Pir could decrease the expression of LC3-II and Beclin-1 induced by EtOH, and increase the phosphorylation of mTOR and reduce the phosphorylation of Akt, which suggested that the protective effect of Pir was involved in regulation of autophagic process and mTOR/Akt pathways. In conclusion, we speculate that Pir reduces EtOH-induced neuronal damage by regulation of apoptotic action and autophagic action, and our research offers preclinical evidence for the application of Pir in ethanol toxicity.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
CNS Depressants: Alcohol and Nicotine
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Antiepileptic Drugs: Glutamate Antagonists

